Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > ECB opposes favourable capital treatment for BNP Paribas' AXA deal, source says
    Finance

    ECB opposes favourable capital treatment for BNP Paribas' AXA deal, source says

    Published by Global Banking & Finance Review®

    Posted on April 11, 2025

    2 min read

    Last updated: January 24, 2026

    ECB opposes favourable capital treatment for BNP Paribas' AXA deal, source says - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    The ECB opposes BNP Paribas' favorable capital treatment for its AXA deal, affecting European financial consolidation.

    ECB Rejects Favorable Capital Treatment for BNP Paribas' AXA Deal

    PARIS (Reuters) -The European Central Bank is opposed to BNP Paribas using a favourable capital treatment for its deal to buy French insurer AXA's asset management business, a person with knowledge of the matter said.

    The ECB's view could have negative implications for consolidation across Europe's financial industry, making certain deals more expensive.

    BNP shares fell on Friday and were last down 2.4%, underperforming the wider European banking sector, which dropped about 0.2%.

    BNP Paribas and AXA declined to comment.

    The ECB declined to comment.

    The French bank had asked the ECB to use what is known as the "Danish Compromise" that provides favourable capital treatment in asset management takeovers carried out through banks' insurance businesses.

    In a media interview published on the ECB website on Friday, Claudia Buch, the ECB's chief supervisor, said the bank's interpretation of the "Danish Compromise" "is that it’s intended to be applied to the insurance sector and not to, for example, asset management undertakings."

    She also noted that the ECB did not make the rules, which was the role of European legislators and the European Banking Authority.

    The Danish Compromise makes an asset management acquisition cheaper for the buyer in terms of the hit to its regulatory capital. It lets banks risk-weight their insurance investments instead of deducting them in full from their capital.

    BNP Paribas's AXA deal was agreed last year but is yet to be finalised.

    The ECB has said previously it would decide on the use of the Danish Compromise on a case-by-case basis.

    Last month, the ECB took a negative stance on Italian bank Banco BPM benefiting from the same rule for its acquisition of a local asset manager.

    BPM has since said it will continue with its bid for Anima Holding.

    Banking executives are keen to see what stance the ECB takes, with industry sources saying a positive opinion on the use of the Danish Compromise would support further dealmaking.

    (Reporting by Florence Loeve, Chandni Shah and Tommy Reggiori Wilkes. Editing by Jane Merriman)

    Key Takeaways

    • •The ECB opposes BNP Paribas' use of favorable capital treatment for the AXA deal.
    • •The decision could impact financial consolidation in Europe.
    • •BNP shares fell 2.4% following the news.
    • •The Danish Compromise is intended for insurance, not asset management.
    • •ECB's stance may influence future banking deals.

    Frequently Asked Questions about ECB opposes favourable capital treatment for BNP Paribas' AXA deal, source says

    1What is the main topic?

    The ECB's opposition to BNP Paribas' favorable capital treatment for its AXA deal.

    2Why is the ECB's decision significant?

    It could make financial consolidations more expensive and impact future banking deals.

    3What is the Danish Compromise?

    A rule allowing banks to risk-weight insurance investments, intended for the insurance sector.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostEni pockets 3.6 billion euros from stake sales in biofuel unit to KKR
    Next Finance PostUS-China tariff war steers gold through $3,200 per ounce